Vestem
A biotechnology pioneer advancing bioveterinary cell therapies and next-gen pharmaceuticals for pet treatments.
General Information
BounceWatch is an independent company data service, not affiliated with Vestem. To contact Vestem, visit vetstem.ru.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Vestem compare?
A PDF of Vestem and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Vestem soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Vestem on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
About Vestem
Business keywords: veterinary medicine, cell therapies, regenerative therapy, pharmaceuticals, pet treatments, animal health, biomedical innovation
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | RUB24.00M | 1 |
|
11 Jan 2024 |
Vestem Alternatives & Competitors
View All Alternatives
A clinical-stage biotechnology company developing novel cell therapies for unmet medical needs.
Focused on the development of precisely targeted, controlled & highly active T cell therapies for ca...
Translating dendritic cell biology into new therapies for cancer and autoimmunity.
FAQ About Vestem
Source: BounceWatch company record for Vestem, https://bouncewatch.com/company/vestem, updated 27 December 2024. When citing, please name BounceWatch and link this page.
